Literature DB >> 11122905

Neuropsychiatric aspects of Alzheimer's disease.

C Ballard1, M Walker.   

Abstract

The increase in research studies focusing on neuropsychiatric symptoms over the last decade has greatly increased our knowledge base, particularly with regard to the frequency of these symptoms and their impact on both patients and carers. We still have a poor understanding of the natural course of these symptoms and their biologic correlates, however, and more specific treatment studies are needed to inform clinical management.

Entities:  

Mesh:

Year:  1999        PMID: 11122905     DOI: 10.1007/s11920-999-0010-4

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  113 in total

1.  Interracial and intraracial differences in neuropsychiatric symptoms, sociodemography, and treatment among nursing home patients with dementia.

Authors:  C I Cohen; K Hyland; C Magai
Journal:  Gerontologist       Date:  1998-06

2.  Association between family history of affective disorder and the depressive syndrome of Alzheimer's disease.

Authors:  G D Pearlson; C A Ross; W D Lohr; B W Rovner; G A Chase; M F Folstein
Journal:  Am J Psychiatry       Date:  1990-04       Impact factor: 18.112

3.  Psychotic symptoms and physically aggressive behavior in Alzheimer's disease.

Authors:  D W Gilley; R S Wilson; L A Beckett; D A Evans
Journal:  J Am Geriatr Soc       Date:  1997-09       Impact factor: 5.562

4.  The prevalence of neuropsychiatric disorders in a nursing home population.

Authors:  J D Chandler; J E Chandler
Journal:  J Geriatr Psychiatry Neurol       Date:  1988 Apr-Jun       Impact factor: 2.680

5.  Research diagnostic criteria: rationale and reliability.

Authors:  R L Spitzer; J Endicott; E Robins
Journal:  Arch Gen Psychiatry       Date:  1978-06

6.  The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia.

Authors:  J L Cummings; M Mega; K Gray; S Rosenberg-Thompson; D A Carusi; J Gornbein
Journal:  Neurology       Date:  1994-12       Impact factor: 9.910

7.  Morning bright light therapy for sleep and behavior disorders in elderly patients with dementia.

Authors:  K Mishima; M Okawa; Y Hishikawa; S Hozumi; H Hori; K Takahashi
Journal:  Acta Psychiatr Scand       Date:  1994-01       Impact factor: 6.392

8.  Delusions in Alzheimer's disease and multi-infarct dementia.

Authors:  G Binetti; A Bianchetti; A Padovani; G Lenzi; D De Leo; M Trabucchi
Journal:  Acta Neurol Scand       Date:  1993-07       Impact factor: 3.209

9.  Instruments for screening for depression and dementia in a long-term care facility.

Authors:  S Kafonek; W H Ettinger; R Roca; S Kittner; N Taylor; P S German
Journal:  J Am Geriatr Soc       Date:  1989-01       Impact factor: 5.562

10.  Neuropsychiatric and neuropsychological correlates of delusions in Alzheimer's disease.

Authors:  R Migliorelli; G Petracca; A Tesón; L Sabe; R Leiguarda; S E Starkstein
Journal:  Psychol Med       Date:  1995-05       Impact factor: 7.723

View more
  4 in total

Review 1.  Dementia with Lewy bodies: clinical features and treatment.

Authors:  S Campbell; S Stephens; C Ballard
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

2.  High dietary fat and sucrose results in an extensive and time-dependent deterioration in health of multiple physiological systems in mice.

Authors:  James G Burchfield; Melkam A Kebede; Christopher C Meoli; Jacqueline Stöckli; P Tess Whitworth; Amanda L Wright; Nolan J Hoffman; Annabel Y Minard; Xiuquan Ma; James R Krycer; Marin E Nelson; Shi-Xiong Tan; Belinda Yau; Kristen C Thomas; Natalie K Y Wee; Ee-Cheng Khor; Ronaldo F Enriquez; Bryce Vissel; Trevor J Biden; Paul A Baldock; Kyle L Hoehn; James Cantley; Gregory J Cooney; David E James; Daniel J Fazakerley
Journal:  J Biol Chem       Date:  2018-02-13       Impact factor: 5.157

3.  Neuroinflammation and neuronal loss precede Aβ plaque deposition in the hAPP-J20 mouse model of Alzheimer's disease.

Authors:  Amanda L Wright; Raphael Zinn; Barbara Hohensinn; Lyndsey M Konen; Sarah B Beynon; Richard P Tan; Ian A Clark; Andrea Abdipranoto; Bryce Vissel
Journal:  PLoS One       Date:  2013-04-01       Impact factor: 3.240

4.  Superior memory performance in healthy individuals with subclinical psychotic symptoms but without genetic load for schizophrenia.

Authors:  G Gagnon; S Kumar; J-R Maltais; A N Voineskos; B H Mulsant; T K Rajji
Journal:  Schizophr Res Cogn       Date:  2018-08-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.